在选择生物药物治疗呼吸道疾病时,以内型为驱动的决策
Carmen Panaitescu1,2, Laura Haidar1, Maria-Roxana Buzan1,2
1Center of Immuno-Physiology and Biotechnologies, Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
对过敏疾病的精准医学需要基于内型的策略. 识别特定的免疫机制 (内型) 引导有针对性的生物选择,以获得更好的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对过敏性疾病的生物疗法正在增加,需要改进患者选择,超越传统的表型.
- 目前对过敏性疾病的管理面临医疗保健成本和治疗疗效的挑战,需要精确的策略.
研究的目的:
- 审查内型在指导喘和带鼻息肉的慢性鼻炎的向生物疗法的作用.
- 为在护理点提供内型导向护理的决策算法.
主要方法:
- 综述当前关于过敏疾病内型和生物疗法的文献.
- 基于1型,2型和3型免疫反应的内型的分类.
- 开发用于内型鉴定和生物选择的决策算法.
主要成果:
- 内型分类对于选择针对特定通路的生物药物至关重要,例如IgE,IL-5,IL-4/IL-13和TSLP.
- 整合到护理途径中的内型驱动方法可以改善患者的结果和满意度.
结论:
- 内型鉴定是个性化,精准医学在过敏性疾病的关键.
- 需要实用解决方案和决策算法来支持广泛采用内型导向治疗策略.
更多相关视频
09:10Heterotopic and Orthotopic Tracheal Transplantation in Mice used as Models to Study the Development of Obliterative Airway Disease
Published on: January 20, 2010
11:51Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
相关概念视频
Choosing Between z and t Distribution
Decision Making
Automatic decision-making is fast, intuitive, and relies on gut feelings...
Biological Effects of Radiation
What is Conservation Biology?
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
Suctioning the Nasopharyngeal Airway
Equipment Required
